Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation

American Journal of Transplantation

Volumn 7, Issue 11, 2007, Pages 2515-2521

  Borchhardt, K ^a   Sulzbacher, I ^a   Benesch, T ^a   Fodinger M ^a   Sunder Plassmann, G ^a   Haas, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bone disease; Hypercalcemia; Hyperparathyroidism; Kidney transplantation

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; DOXYCYCLINE; FIBROBLAST GROWTH FACTOR 23; MINOCYCLINE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE DISEASE; BONE TURNOVER; CALCULATION; CLINICAL ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; HYPERCALCEMIC HYPERPARATHYROIDISM; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; MALE; OSSIFICATION; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; SEROLOGY; STATISTICAL SIGNIFICANCE;

AGED; ALKALINE PHOSPHATASE; BIOPSY; BONE DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OSTEOCALCIN; POSTOPERATIVE COMPLICATIONS; RENAL OSTEODYSTROPHY;

EID: 35248873344     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01950.x     Document Type: Article

References (33)

1. Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 2002 13 : 551 558.
2. Bonarek H, Merville P, Bonarek M et al. Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int 1999 56 : 642 649.
3. D'Alessandro AM, Melzer JS, Pirsch JD et al. Tertiary hyperparathyroidism after renal transplantation: Operative Indications. Surgery 1989 106 : 1049 1055.
4. Parfitt AM. Hypercalcemic hyperparathyroidism following renal transplantation: Differential diagnosis, management, and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab 1982 8 : 92 112.
5. Garvin PJ, Castaneda M, Linderer R, Dickhans M. Management of hypercalcemic hyperparathyroidism after renal transplantation. Arch Surg 1985 120 : 578 583.
6. Heaf J. Bone disease after renal transplantation. Transplantation 2003 75 : 315 325.
7. Gwinner W, Suppa S, Mengel M et al. Early calcification of renal allografts detected by protocol biopsies: Causes and clinical implications. Am J Transplant 2005 5 : 1934 1941.
8. Triponez F, Dosseh D, Hazzan M, Noel C, Vanhille P, Proye CAG. Subtotal parathyroidectomy with thymectomy for autonomous hyperparathyroidism after renal transplantation. Br J Surg 2005 92 : 1282 1287.
9. Triponez F, Kebebew E, Dosseh D et al. Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. Surgery 2006 140 : 990 997.
10. National Kidney Foundation : K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 2003 42 (4 Suppl 3 S1 S201.
11. Iwasaki Y, Yamato H, Nii-Kono T et al. Insufficiency of PTH action on bone in uremia. Kidney Int Suppl 2006 102 : S34 S36.
12. Mathew S, Davies M, Lund R, Saab G, Hruska KA. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease. Eur J Clin Invest 2006 36 : 43 50.
13. Haas M, Leko-Mohr Z, Roschger P et al. Zoledronic acid to prevent bone loss in the first six months after renal transplantation. Kidney Int 2003 63 : 1130 1136.
14. Parfitt AM, Drezner MK, Glorieux FH et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987 2 : 595 610.
15. Aaron JE, Shore PA. Bone histomorphometry: Concepts and common techniques. In : Yuehuei AH, Kylie ML (eds). Handbook of Histology Methods for Bone and Cartilage, 1th Ed., Humana Press Inc. 2003 : 331 351.
16. Moe S, Drueke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006 69 : 1945 1953.
17. Grotz WH, Mundinger FA, Gugel B, Exner V, Kirste G, Schollmeyer PJ. Bone fracture and osteodensitometry wit dual energy x-ray absorptiometry in kidney transplant recipients. Transplantation 1994 58 : 912 915.
18. Cundy T, Kanis JA, Heynen G, Morris PJ, Oliver DO. Calcium metabolism and Hyperparathyroidism after renal transplantation. QJM 1983 205 : 67 78.
19. Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005 20 : 1311 1314.
20. Serra AL, Schwarz AA, Wick FH, Marti HP, Wüthrich RP. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 2005 20 : 1315 1319.
21. Srinivas TR, Schold JD, Womer KL et al. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol 2006 1 : 323 326.
22. Casez JP, Lippuner K, Horber FF, Montandon A, Jaeger P. Changes in bone mineral density over 18 months following kidney transplantation: The respective roles of prednisone and parathyroid hormone. Nephrol Dial Transplant 2002 17 : 1318 1326.
23. Shigematsu T, Kazama JJ, Yamashita T et al. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 2004 44 : 250 256.
24. Larsson T, Nisbeth U, Ljunggren Ö, Jüppner H, Jonsson KB. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003 64 : 2272 2279.
25. Parfitt AM, Kleerkoper M, Cruz C. Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: Implications for the pathogenesis of hyperparathyroidism in chronic renal failure. Miner Electrolyte Metab 1986 12 : 356 362.
26. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid bone loss of vertebral mineral density after renal transplantation. N Engl J Med 1991 325 : 544 550.
27. Velasquez-Forero F, Mondragón A, Herrero B, Penta JC. Adynamic bone lesion in renal transplant recipients with normal renal function. Nephrol Dial Transplant 1996 11 (Suppl 3 58 64.
28. Carlini RG, Rojas E, Weisinger JR et al. Bone disease in patients with long-term renal transplantation and normal renal function. Am J Kidney Dis 2000 1 : 160 166.
29. Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 2000 11 : 1093 1099.
30. Montalban C, de Francisco AL, Marinoso ML et al. Bone disease in long-term adult kidney transplant patients with normal renal function. Kidney Int 2003 63 (Suppl 85 S129 S132.
31. Coco M, Glicklich D, Faugere MC et al. Prevention of bone loss in renal transplant recipients: A prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol 2003 14 : 2669 2676.
32. Cueto-Manzano AM, Konel S, Hutchison AJ et al. Bone loss in long-term renal transplantation: Histopathology and densitometry analysis. Kidney Int 1999 55 : 2021 2029.
33. Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: A single centre study. Nephrol Dial Transplant 2005 20 : 1714 1720.